Cargando…

Prognostic effect of atrial fibrillation on survival in patients with hypertrophic cardiomyopathy: a meta-analysis

OBJECTIVE: To systematically evaluate the prognostic impact of atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM). METHODS: The Chinese and English databases (PubMed, EMBASE, Cochrane Library, Chinese National Knowledge Infrastructure, and Wanfang database were systematicall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Meiling, Wang, Xiaoyuan, Zhang, Aiai, Li, Feixing, Yi, Mengyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283177/ https://www.ncbi.nlm.nih.gov/pubmed/37340493 http://dx.doi.org/10.1186/s13019-023-02299-x

Ejemplares similares

Evaluation of ABC Bleeding Score and SAMe-TT2R2 Score on the Risk of Bleeding after Anticoagulation in Patients with Nonvalvular Atrial Fibrillation Complicated with Coronary Heart Disease
por: Du, Meiling, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
por: Palyam, Vishnu, et al.
Publicado: (2022)

Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis
por: Liu, Qun, et al.
Publicado: (2017)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2023)

Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
por: Tian, Hongwei, et al.
Publicado: (2018)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

State-of-the-Art Treatments for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Penela, Diego, et al.
Publicado: (2021)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Rozen, Guy, et al.
Publicado: (2020)

Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning)
por: Estes, N. A. Mark, et al.
Publicado: (2021)

Clinical significance of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2021)

Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy
por: Khawaja, Tasveer, et al.
Publicado: (2023)

Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure
por: Ikenaga, Hiroki, et al.
Publicado: (2017)

Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Xiangbin, et al.
Publicado: (2022)

Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
por: Doesch, Christina, et al.
Publicado: (2016)

Cardiac MRI predictors for development of atrial fibrillation or flutter in patients with hypertrophic cardiomyopathy
por: She, Helen Hoi Lam, et al.
Publicado: (2015)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
por: Ahluwalia, N, et al.
Publicado: (2023)

Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: A proportional meta-analysis and systematic review of single-arm studies
por: Latif, Azka, et al.
Publicado: (2023)

Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy
por: Nedios, Sotirios, et al.
Publicado: (2021)

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy
por: Bogachev-Prokophiev, A, et al.
Publicado: (2015)

Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy
por: Liu, Li-Min, et al.
Publicado: (2020)

Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study
por: Hsu, Jung-Chi, et al.
Publicado: (2020)

Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy
por: Komatsu, Junya, et al.
Publicado: (2021)

Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
por: Choi, You-Jung, et al.
Publicado: (2022)

Association of Types of Sleep Apnea and Nocturnal Hypoxemia with Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Xu, Haobo, et al.
Publicado: (2023)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction
por: Li, Huixian, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy: Ischemia progressing to ventricular fibrillation
por: Rochelson, Ellis, et al.
Publicado: (2018)

Longitudinal Changes of Left Atrial Volume Index as a Prognosticator in Hypertrophic Cardiomyopathy
por: Kim, Sungseek, et al.
Publicado: (2023)

Left Atrial Appendage Closure for Primary and Secondary Stroke Prevention in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Pilot Study
por: Mo, Bin-Feng, et al.
Publicado: (2021)

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
por: Pioner, Josè Manuel, et al.
Publicado: (2022)

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
por: An, Myeonghyun, et al.
Publicado: (2023)

Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long‐Term Outcome
por: Dinshaw, Leon, et al.
Publicado: (2021)

Atrial Cardiomyopathy and Atrial Fibrillation in Cancer
por: Ren, Mengdi, et al.
Publicado: (2021)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
por: Siontis, Konstantinos C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p7l262ii3ua77sl8em5us6e9go